Phase I study of neoadjuvant 5-fluorouracil (5FU) chemoradiation (CRT) and trametinib in patients with locally advanced rectal cancers (LARC).

Authors

Christina Wu

Christina Sing-Ying Wu

Emory University, Atlanta, GA

Christina Sing-Ying Wu , Terence M Williams , Lai Wei , Hamida Umar , Sameh Mikhail , Kristen Keon Ciombor , Anne M. Noonan , Sameek Roychowdhury , Samer S El-Dika , Somashekar Krishna , Bennie Upchurch , Sean T McCarthy , Mark Arnold , Alan Harzman , Sherif Abdel-Misih , William Cirocco , Amber Traugott , Tanios S. Bekaii-Saab , Evan John Wuthrick

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01740648

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 685)

DOI

10.1200/JCO.2017.35.4_suppl.685

Abstract #

685

Poster Bd #

H15

Abstract Disclosures